Physician profile
James E Benjamin
NPI 1932562352
$2,701.57
in general payments reported to CMS, 2019-2025
19 companies · $682 in 2025
The $682 reported for 2025 was more than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $22.37 · 2022: $535 · 2023: $831 · 2024: $631 · 2025: $682.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,144.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,144.39 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $1,000.48 | 2022-2025 | Eylea, Eylea Hd |
| Genentech USA, INC. | $461.04 | 2022-2025 | Vabysmo |
| Alimera Sciences, INC. | $204.56 | 2022-2024 | Iluvien, Yutiq |
| Apellis Pharmaceuticals, INC. | $181.46 | 2023-2025 | Syfovre |
| Abbvie INC. | $129.46 | 2022-2025 | Ozurdex |
| Coherus Oncology, INC. | $119.10 | 2022-2023 | |
| Genentech, INC. | $99.09 | 2023-2024 | Vabysmo |
| Biogen, INC. | $98.03 | 2022-2024 | Byooviz |
| Astellas Pharma US INC | $84.28 | 2023-2025 | Izervay |
| Alcon Vision LLC | $83.51 | 2022-2025 | Tryptyr, Argos, Simbrinza |
| Bausch & Lomb Americas INC. | $44.61 | 2023-2025 | Xiidra, Xipere |
| Harrow Eye, LLC | $43.25 | 2024-2025 | Vevye |
| Organogenesis INC. | $27.90 | 2025 | Novachor |
| Carl Zeiss Meditec USA, INC. | $26.16 | 2024 | |
| Sun Pharmaceutical Industries INC. | $25.75 | 2023 | Cequa |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eyepoint US, INC. | $22.37 | 2021 | |
| Novartis Pharmaceuticals Corporation | $20.65 | 2022 | |
| Oyster Point Pharma, INC. | $15.75 | 2023 | Tyrvaya |
| Ani Pharmaceuticals, INC. | $14.12 | 2024 | Purified Cortrophin Gel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Benjamin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.